Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
0-13 |
JJ |
denotes |
Site-specific |
T1 |
14-20 |
NN |
denotes |
glycan |
T2 |
21-29 |
NN |
denotes |
analysis |
T3 |
30-32 |
IN |
denotes |
of |
T4 |
33-36 |
DT |
denotes |
the |
T5 |
37-47 |
NN |
denotes |
SARS-CoV-2 |
T6 |
48-53 |
NN |
denotes |
spike |
T7 |
55-65 |
NN |
denotes |
SARS-CoV-2 |
T8 |
66-71 |
NN |
denotes |
spike |
T9 |
72-79 |
NN |
denotes |
protein |
T10 |
79-80 |
-COMMA- |
denotes |
, |
T11 |
81-91 |
VBD |
denotes |
elaborated |
T12 |
92-99 |
NN |
denotes |
Vaccine |
T13 |
100-111 |
NN |
denotes |
development |
T14 |
112-115 |
IN |
denotes |
for |
T15 |
116-122 |
JJ |
denotes |
severe |
T16 |
123-128 |
JJ |
denotes |
acute |
T17 |
129-140 |
JJ |
denotes |
respiratory |
T18 |
141-149 |
NN |
denotes |
syndrome |
T19 |
150-161 |
NN |
denotes |
coronavirus |
T20 |
162-163 |
CD |
denotes |
2 |
T21 |
164-165 |
-LRB- |
denotes |
( |
T22 |
165-175 |
NN |
denotes |
SARS-CoV-2 |
R0 |
T2 |
T0 |
arg1Of |
analysis,Site-specific |
R1 |
T2 |
T1 |
arg1Of |
analysis,glycan |
R10 |
T13 |
T12 |
arg1Of |
development,Vaccine |
R11 |
T13 |
T14 |
arg1Of |
development,for |
R12 |
T19 |
T14 |
arg2Of |
coronavirus,for |
R13 |
T19 |
T15 |
arg1Of |
coronavirus,severe |
R14 |
T19 |
T16 |
arg1Of |
coronavirus,acute |
R15 |
T19 |
T17 |
arg1Of |
coronavirus,respiratory |
R16 |
T19 |
T18 |
arg1Of |
coronavirus,syndrome |
R17 |
T19 |
T20 |
arg1Of |
coronavirus,2 |
R18 |
T19 |
T21 |
arg1Of |
coronavirus,( |
R19 |
T22 |
T21 |
arg2Of |
SARS-CoV-2,( |
R2 |
T2 |
T3 |
arg1Of |
analysis,of |
R3 |
T6 |
T3 |
arg2Of |
spike,of |
R4 |
T6 |
T4 |
arg1Of |
spike,the |
R5 |
T6 |
T5 |
arg1Of |
spike,SARS-CoV-2 |
R6 |
T9 |
T7 |
arg1Of |
protein,SARS-CoV-2 |
R7 |
T9 |
T8 |
arg1Of |
protein,spike |
R8 |
T11 |
T10 |
arg1Of |
elaborated,"," |
R9 |
T9 |
T11 |
arg1Of |
protein,elaborated |